In a melanoma metastatic model, however, we found that iGb3 (20 μg/ml)-loaded CD11c+CD1d+ BMDCs reduced the number of lung nodules 4-fold, the same level of anti tumor protection obtained with α-GalCer at 200 ng/ml. Here, ITGAX is linked to neoplasm.